Investor Information
At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.
Disclosure Under Regulation 30
Update on Acquisition of UractivTM Portfolio – 28th September, 2022
Stock Exchange Letter Intimation of Schedule of Analyst / Institutional Investor Meeting
Stock Exchange Letter Intimation of Schedule of Analyst / Institutional Investor Meeting
Proceedings of 30th AGM and intimation of Change in the Board of Directors
Chairman’s Speech at 30th AGM of the Company
Update on US FDA Inspection at Mohali Facility
Update on US FDA Inspection at Halol facility
Cessation of Compliance Officer
Approval of Scheme of Amalgamation
Appointment of Lead Independent Director/ Re-appointment of Directors